CoChat
Sign Up
Cited by 25

The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.

Autoimmune Disorders in Heart Failure With Preserved Ejection Fraction

Tada, Atsushi, Doi, Shunichi, Harada, Tomonari, Ibe, Tatsuro, Naser, Jwan A., Amdahl, Matthew, Reddy, Yogesh N.V., Borlaug, Barry A.·2024·JACC: Heart Failure
DOI 10.1016/j.jchf.2024.04.016
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.jchf.2024.04.016

Cites

8 of 8 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Flagged first, then by citations

Research works printed but not linked: 36

  1. Redfield, 2023, Heart failure with preserved ejection fraction: a review, JAMA, 329, 827, 10.1001/jama.2023.2020 · DOI · Paper page
  2. Pugliese, 2023, Inflammatory pathways in heart failure with preserved left ventricular ejection fraction: implications for future interventions, Cardiovasc Res, 118, 3536, 10.1093/cvr/cvac133 · DOI
  3. Alogna, 2023, Interleukin-6 in patients with heart failure and preserved ejection fraction, J Am Coll Cardiol HF, 11, 1549
  4. Sorimachi, 2022, Sex and central obesity in heart failure with preserved ejection fraction, Eur J Heart Fail, 24, 1359, 10.1002/ejhf.2563 · DOI
  5. Sorimachi, 2021, Pathophysiologic importance of visceral adipose tissue in women with heart failure and preserved ejection fraction, Eur Heart J, 42, 1595, 10.1093/eurheartj/ehaa823 · DOI · Paper page
  6. Schiattarella, 2021, Metabolic inflammation in heart failure with preserved ejection fraction, Cardiovasc Res, 117, 423, 10.1093/cvr/cvaa217 · DOI · Paper page
  7. Paulus, 2013, A novel paradigm for heart failure with preserved ejection fraction: comorbidities drive myocardial dysfunction and remodeling through coronary microvascular endothelial inflammation, J Am Coll Cardiol, 62, 263, 10.1016/j.jacc.2013.02.092 · DOI · Paper page
  8. Amigues, 2019, Myocardial microvascular dysfunction in rheumatoid arthritis(quantitation by (13)N-ammonia positron emission tomography/computed tomography), Circ Cardiovasc Imaging, 12, 10.1161/CIRCIMAGING.117.007495 · DOI
  9. Mantel, 2017, Association between rheumatoid arthritis and risk of ischemic and nonischemic heart failure, J Am Coll Cardiol, 69, 1275, 10.1016/j.jacc.2016.12.033 · DOI
  10. Davis, 2017, Five-year changes in cardiac structure and function in patients with rheumatoid arthritis compared with the general population, Int J Cardiol, 240, 379, 10.1016/j.ijcard.2017.03.108 · DOI
  11. Sandhu, 2020, Five-year follow-up of coronary microvascular dysfunction and coronary artery disease in systemic lupus erythematosus: results from a community-based lupus cohort, Arthritis Care Res (Hoboken), 72, 882, 10.1002/acr.23920 · DOI
  12. Elnady, 2016, The implication of tissue Doppler echocardiography and cardiopulmonary exercise in early detection of cardiac dysfunction in systemic lupus erythematosus patients, Eur J Rheumatol, 3, 109
  13. Porpaczy, 2018, Impairment of left atrial mechanics is an early sign of myocardial involvement in systemic sclerosis, J Card Fail, 24, 234, 10.1016/j.cardfail.2018.02.012 · DOI
  14. Rodriguez-Reyna, 2015, Assessment of myocardial fibrosis and microvascular damage in systemic sclerosis by magnetic resonance imaging and coronary angiotomography, Rheumatology (Oxford), 54, 647, 10.1093/rheumatology/keu350 · DOI
  15. Pandey, 2021, Exercise intolerance in older adults with heart failure with preserved ejection fraction: JACC state-of-the-art review, J Am Coll Cardiol, 78, 1166, 10.1016/j.jacc.2021.07.014 · DOI · Paper page
  16. Upadhya, 2015, Exercise intolerance in heart failure with preserved ejection fraction: more than a heart problem, J Geriatr Cardiol, 12, 294
  17. Ponikowski, 2001, Enhanced ventilatory response to exercise in patients with chronic heart failure and preserved exercise tolerance: marker of abnormal cardiorespiratory reflex control and predictor of poor prognosis, Circulation, 103, 967, 10.1161/01.CIR.103.7.967 · DOI
  18. Melamed, 2019, Unexplained exertional intolerance associated with impaired systemic oxygen extraction, Eur J Appl Physiol, 119, 2375, 10.1007/s00421-019-04222-6 · DOI
  19. Lang, 2015, Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging, J Am Soc Echocardiogr, 28, 1, 10.1016/j.echo.2014.10.003 · DOI · Paper page
  20. Borlaug, 2016, Abnormal right ventricular-pulmonary artery coupling with exercise in heart failure with preserved ejection fraction, Eur Heart J, 37, 3293, 10.1093/eurheartj/ehw241 · DOI
  21. El-Gabalawy, 2010, Epidemiology of immune-mediated inflammatory diseases: incidence, prevalence, natural history, and comorbidities, J Rheumatol Suppl, 85, 2, 10.3899/jrheum.091461 · DOI
  22. Patel, 2014, The epidemiology of Sjogren's syndrome, Clin Epidemiol, 6, 247
  23. Bairkdar, 2021, Incidence and prevalence of systemic sclerosis globally: a comprehensive systematic review and meta-analysis, Rheumatology (Oxford), 60, 3121, 10.1093/rheumatology/keab190 · DOI
  24. Sun, 2023, Long-term risk of heart failure and other adverse cardiovascular outcomes in primary Sjogren's syndrome, J Intern Med, 293, 457, 10.1111/joim.13595 · DOI
  25. Omote, 2023, Left atrial myopathy in heart failure with preserved ejection fraction, Circ J, 87, 1039, 10.1253/circj.CJ-21-0795 · DOI
  26. Dhakal, 2015, Mechanisms of exercise intolerance in heart failure with preserved ejection fraction: the role of abnormal peripheral oxygen extraction, Circ Heart Fail, 8, 286, 10.1161/CIRCHEARTFAILURE.114.001825 · DOI
  27. Khor, 2017, Hypothalamic and inflammatory basis of hypertension, Clin Sci (Lond), 131, 211, 10.1042/CS20160001 · DOI
  28. Reddy, 2021, Peripheral and pulmonary effects of inorganic nitrite during exercise in heart failure with preserved ejection fraction, Eur J Heart Fail, 23, 814, 10.1002/ejhf.2093 · DOI
  29. Verbrugge, 2020, Altered hemodynamics and end-organ damage in heart failure: impact on the lung and kidney, Circulation, 142, 998, 10.1161/CIRCULATIONAHA.119.045409 · DOI
  30. Lewis, 2008, Determinants of ventilatory efficiency in heart failure: the role of right ventricular performance and pulmonary vascular tone, Circ Heart Fail, 1, 227, 10.1161/CIRCHEARTFAILURE.108.785501 · DOI
  31. Black, 2023, Mortality estimates and excess mortality in rheumatoid arthritis, Rheumatology (Oxford), 10.1093/rheumatology/kead106 · DOI
  32. Bultink, 2021, Mortality, causes of death and influence of medication use in patients with systemic lupus erythematosus vs matched controls, Rheumatology (Oxford), 60, 207, 10.1093/rheumatology/keaa267 · DOI
  33. Van Tassell, 2014, Effects of interleukin-1 blockade with anakinra on aerobic exercise capacity in patients with heart failure and preserved ejection fraction (from the D-HART pilot study), Am J Cardiol, 113, 321, 10.1016/j.amjcard.2013.08.047 · DOI
  34. Van Tassell, 2018, IL-1 blockade in patients with heart failure with preserved ejection fraction, Circ Heart Fail, 11, 10.1161/CIRCHEARTFAILURE.118.005036 · DOI
  35. Everett, 2019, Anti-inflammatory therapy with canakinumab for the prevention of hospitalization for heart failure, Circulation, 139, 1289, 10.1161/CIRCULATIONAHA.118.038010 · DOI · Paper page
  36. Lund, 2023, Rationale and design of ENDEAVOR: a sequential phase 2b-3 randomized clinical trial to evaluate the effect of myeloperoxidase inhibition on symptoms and exercise capacity in heart failure with preserved or mildly reduced ejection fraction, Eur J Heart Fail, 25, 1696, 10.1002/ejhf.2977 · DOI

Cited by

Sorted by citations

Metadata

Authors
Tada, A., Doi, S., Harada, T., Ibe, T., Naser, J. A., Amdahl, M., Reddy, Y. N. V., & Borlaug, B. A.
Venue
JACC: Heart Failure
Publisher
Elsevier BV
Published
2024-07
Volume
12
Issue
7
Pages
1257-1269
ISSN
2213-1779
DOI
10.1016/j.jchf.2024.04.016
Cited by
25
References
8
Language
en
Licence
Funders
  • DOD
  • NIH

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review